GS
RYTM icon

GTS Securities’s Rhythm Pharmaceuticals RYTM Stock Holding History

GTS Securities’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,800
Closed -$513K – 3504
2024
Q3 		$513K Buy
9,800
+100
+1% +$4.79K ﹤0.01% 2803
2024
Q2 		$398K Buy
9,700
+700
+8% +$27.9K ﹤0.01% 2886
2024
Q1 		$390K Buy
9,000
+2,800
+45% +$123K ﹤0.01% 2783
2023
Q4 		$285K Buy
+6,200
New +$196K ﹤0.01% 3254

Other funds holding RYTM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GTS Securities's RYTM Position: Q3 2024 in Review

GTS Securities sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2024, closing a stake of 23,136 shares — an estimated $1.11M sold.

GTS Securities first reported a position in RYTM in Q2 2024 and held it in 1 quarter. The position peaked at $950K in Q2 2024. 176 funds tracked by Wall St. Rank hold RYTM as of Q3 2024.

  • GTS Securities reported no remaining Rhythm Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • GTS Securities sold 23,136 Rhythm Pharmaceuticals shares in Q3 2024, an estimated $1.11M.
  • GTS Securities first reported a position in Rhythm Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • GTS Securities's Rhythm Pharmaceuticals position peaked at $950K in Q2 2024.
  • 176 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.